These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8967355)

  • 21. Agonist-independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells.
    Hanf R; Li Y; Szabo G; Fischmeister R
    J Physiol; 1993 Feb; 461():743-65. PubMed ID: 8350280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla.
    Imbrogno S; De Iuri L; Mazza R; Tota B
    J Exp Biol; 2001 May; 204(Pt 10):1719-27. PubMed ID: 11316492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
    Finkel MS; Oddis CV; Mayer OH; Hattler BG; Simmons RL
    J Pharmacol Exp Ther; 1995 Feb; 272(2):945-52. PubMed ID: 7531767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
    Harding SE; Davies CH; Money-Kyrle AM; Poole-Wilson PA
    Cardiovasc Res; 1998 Dec; 40(3):523-9. PubMed ID: 10070493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cardiac calcium current by NO and cGMP-modulating agents.
    Gallo MP; Malan D; Bedendi I; Biasin C; Alloatti G; Levi RC
    Pflugers Arch; 2001 Feb; 441(5):621-8. PubMed ID: 11294243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation.
    Sears CE; Choate JK; Paterson DJ
    J Appl Physiol (1985); 1998 May; 84(5):1596-603. PubMed ID: 9572804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.
    Kilter H; Lenz O; La Rosée K; Flesch M; Schwinger RH; Mädge M; Kuhn-Regnier F; Böhm M
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):308-12. PubMed ID: 8584047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man.
    Schmetterer L; Dallinger S; Polak K; Eichler HG; Wolzt M
    Nitric Oxide; 1999 Jun; 3(3):209-15. PubMed ID: 10442852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of L-NOARG and L-NAME on basal blood flow and ACh-induced vasodilatation in rat diaphragmatic microcirculation.
    Chang HY; Chen CW; Hsiue TR
    Br J Pharmacol; 1997 Jan; 120(2):326-32. PubMed ID: 9117127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.
    Hare JM; Kim B; Flavahan NA; Ricker KM; Peng X; Colman L; Weiss RG; Kass DA
    J Clin Invest; 1998 Mar; 101(6):1424-31. PubMed ID: 9502785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholine inhibits Ca2+ current by acting exclusively at a site proximal to adenylyl cyclase in frog cardiac myocytes.
    Jurevicius J; Fischmeister R
    J Physiol; 1996 Mar; 491 ( Pt 3)(Pt 3):669-75. PubMed ID: 8815202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of acetylcholine on calcium and potassium currents in frog atrium and ventricle.
    Hartzell HC; Simmons MA
    J Physiol; 1987 Aug; 389():411-22. PubMed ID: 2445977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic modulation of calcium current in neurones from the interatrial septum of bull-frog heart.
    Tse A; Clark RB; Giles WR
    J Physiol; 1990 Aug; 427():127-49. PubMed ID: 2170634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect of nitric oxide synthase inhibitors on acetylcholine-induced relaxation of rat pulmonary and celiac artery rings.
    Yaghi A; Paterson NA; McCormack DG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):279-86. PubMed ID: 9196853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of fetal endothelium-dependent relaxation in a rat model of preeclampsia by chronic nitric oxide synthase inhibition.
    Martínez-Orgado J; González R; Alonso MJ; Salaices M
    J Soc Gynecol Investig; 2004 Feb; 11(2):82-8. PubMed ID: 14980309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.
    Yamamoto S; Tsutsui H; Tagawa H; Saito K; Takahashi M; Tada H; Yamamoto M; Katoh M; Egashira K; Takeshita A
    Circulation; 1997 Mar; 95(5):1111-4. PubMed ID: 9054836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocardial endothelium mediates luminal ACh-NO signaling in isolated frog heart.
    Gattuso A; Mazza R; Pellegrino D; Tota B
    Am J Physiol; 1999 Feb; 276(2):H633-41. PubMed ID: 9950865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acetylcholine on spontaneous contractions in isolated bovine mesenteric lymphatics.
    Yokoyama S; Ohhashi T
    Am J Physiol; 1993 May; 264(5 Pt 2):H1460-4. PubMed ID: 8498560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro.
    Ramnarine SI; Khawaja AM; Barnes PJ; Rogers DF
    Br J Pharmacol; 1996 Jun; 118(4):998-1002. PubMed ID: 8799574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
    Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.